Fresh news on business and economy in Louisiana

Provided by AGP

Louisiana Business Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Business Tribune.

Press releases published on April 29, 2026

OBOOK Holdings Inc. Announces Financial Results for the Full Year 2025 Ended December 31, 2025
Origin Bancorp, Inc. Announces Entry Into Birmingham, Alabama Hires Will Hawkins, Nick Petelos, Adam Pierce, and Nathan Nix
Sprott Announces Date for 2026 First Quarter Results Webcast
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
BondBloxx Announces Upcoming Changes to its ETF Lineup
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Camping World Holdings, Inc. to Secure Counsel Before Important Deadline in Securities Class Action – CWH
Beacon Financial Corporation Announces First Quarter Results
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm- POET 
Walter Law Group Publishes New Report Explaining Wrongful Dismissal Criteria in Canada
Notice of Proposed Settlement of Stockholder Derivative Action: Maison Solutions Inc.
Athene Holding Ltd. Declares Second Quarter 2026 Preferred Stock Dividends
FTAI Aviation Ltd. Reports First Quarter 2026 Results, Increases Dividend to $0.45 per Ordinary Share
Bel Reports First Quarter 2026 Results
Cohen & Company Sets Release Date for First Quarter 2026 Financial Results
Diversified Energy Announces Timing of First Quarter 2026 Results
Mueller Water Products Announces Quarterly Dividend
Palomar Holdings, Inc. Announces First Quarter 2026 Financial Results Release Date and Conference Call
Plexus Announces Planned Chief Financial Officer Transition
Axis Capital Reports First Quarter Net Income Available to Common Shareholders of $247 Million, or $3.29 Per Diluted Common Share and Operating Income of $257 Million, or $3.42 Per Diluted Common Share
Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights

Share us

on your social networks:

Sign up for:

Louisiana Business Tribune

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.